Abstract
Bone is a tissue with high regeneration capacity, but in some situations, the extent of injury prevents tissue repair. In this scenario, cell therapy using bone marrow-derived mesenchymal stem cells (MSCs) has attracted the attention of several research groups because it is a promising alternative to existing treatments. Bone morphogenetic proteins (BMPs) are cytokines belonging to the tr…